Syndax Pharmaceuticals to Participate in Four Investor Conferences

By Public Technologies
  • Syndax Pharmaceuticals CEO Michael A. Metzger and management will participate in four investor conferences in November 2026.
  • Guggenheim 3rd Annual Healthcare Innovation Conference in Boston includes a fireside chat Nov. 10 at 11 a.m. ET.
  • At the Stifel 2026 Healthcare Conference in New York, a fireside chat is scheduled for Nov. 12 at 9:20 a.m. ET.
  • UBS Global Biopharma Conference 2026 in London features a fireside chat Nov. 17 at noon GMT/7 a.m. ET.
  • The Jefferies London Healthcare Conference fireside chat takes place in London Nov. 19 at 12:30 p.m. GMT/7:30 a.m. ET.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610300700PRIMZONEFULLFEED9856407) on October 30, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.